L&C BIO Co.,LTD

KOSDAQ:A290650 Stock Report

Market Cap: ₩1.6t

L&C BIOLTD Future Growth

Future criteria checks 6/6

L&C BIOLTD is forecast to grow earnings and revenue by 155% and 61.3% per annum respectively. EPS is expected to grow by 155.3% per annum. Return on equity is forecast to be 26.4% in 3 years.

Key information

155.0%

Earnings growth rate

155.34%

EPS growth rate

Biotechs earnings growth40.6%
Revenue growth rate61.3%
Future return on equity26.40%
Analyst coverage

Low

Last updated18 Apr 2026

Recent future growth updates

No updates

Recent updates

L&C BIO Co.,LTD's (KOSDAQ:290650) P/S Is Still On The Mark Following 51% Share Price Bounce

Jan 30
L&C BIO Co.,LTD's (KOSDAQ:290650) P/S Is Still On The Mark Following 51% Share Price Bounce

L&C BIO Co.,LTD's (KOSDAQ:290650) Price In Tune With Revenues

Nov 29
L&C BIO Co.,LTD's (KOSDAQ:290650) Price In Tune With Revenues

L&C BIOLTD's (KOSDAQ:290650) Performance Raises Some Questions

Apr 01
L&C BIOLTD's (KOSDAQ:290650) Performance Raises Some Questions

There's No Escaping L&C BIO Co.,LTD's (KOSDAQ:290650) Muted Revenues Despite A 30% Share Price Rise

Dec 14
There's No Escaping L&C BIO Co.,LTD's (KOSDAQ:290650) Muted Revenues Despite A 30% Share Price Rise

Is L&C BIOLTD (KOSDAQ:290650) A Risky Investment?

Nov 12
Is L&C BIOLTD (KOSDAQ:290650) A Risky Investment?

Here's Why L&C BIOLTD (KOSDAQ:290650) Has A Meaningful Debt Burden

Aug 06
Here's Why L&C BIOLTD (KOSDAQ:290650) Has A Meaningful Debt Burden

What L&C BIO Co.,LTD's (KOSDAQ:290650) 27% Share Price Gain Is Not Telling You

Jul 05
What L&C BIO Co.,LTD's (KOSDAQ:290650) 27% Share Price Gain Is Not Telling You

L&C Bio's (KOSDAQ:290650) Performance Raises Some Questions

Mar 27
L&C Bio's (KOSDAQ:290650) Performance Raises Some Questions

Does L&C Bio (KOSDAQ:290650) Deserve A Spot On Your Watchlist?

Apr 20
Does L&C Bio (KOSDAQ:290650) Deserve A Spot On Your Watchlist?

L&C Bio's (KOSDAQ:290650) Earnings Are Of Questionable Quality

Apr 01
L&C Bio's (KOSDAQ:290650) Earnings Are Of Questionable Quality

Is L&C Bio (KOSDAQ:290650) A Risky Investment?

Mar 02
Is L&C Bio (KOSDAQ:290650) A Risky Investment?

Announcing: L&C Bio (KOSDAQ:290650) Stock Increased An Energizing 163% In The Last Year

Feb 03
Announcing: L&C Bio (KOSDAQ:290650) Stock Increased An Energizing 163% In The Last Year

What Is The Ownership Structure Like For L&C Bio Co., Ltd (KOSDAQ:290650)?

Jan 04
What Is The Ownership Structure Like For L&C Bio Co., Ltd (KOSDAQ:290650)?

Should You Be Excited About L&C Bio Co., Ltd's (KOSDAQ:290650) 16% Return On Equity?

Dec 08
Should You Be Excited About L&C Bio Co., Ltd's (KOSDAQ:290650) 16% Return On Equity?

Earnings and Revenue Growth Forecasts

KOSDAQ:A290650 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2027332,60074,00061,40087,1001
12/31/2026135,6003,100-5,45015,4502
12/31/202585,476-138,285-4,47112,565N/A
9/30/202579,99278,706-8966,858N/A
6/30/202575,977125,843-7,200783N/A
3/31/202573,234141,092-14,300-8,570N/A
12/31/202472,032145,038-13,911-8,567N/A
9/30/202466,991-3,649-42,845-15,715N/A
6/30/202469,00950,471-39,492-15,002N/A
3/31/202467,66150,154-32,927-8,488N/A
12/31/202365,92748,689-37,057-12,133N/A
9/30/202367,48753,593-10,164-5,401N/A
6/30/202359,7164,114-28,029-6,684N/A
3/31/202356,3703,882-43,417-10,237N/A
12/31/202252,5724,544-43,594-6,076N/A
9/30/202250,39911,092-43,263-5,744N/A
6/30/202249,55312,530-20,9223,186N/A
3/31/202247,10113,176-2,82510,715N/A
12/31/202145,67713,814-48110,907N/A
9/30/202141,57911,0211,36913,245N/A
6/30/202137,95611,1468639,259N/A
3/31/202135,14111,1072,7678,296N/A
12/31/202032,97310,8134,3647,419N/A
9/30/202031,8687,2135,0407,791N/A
6/30/202030,4106,9784,6887,465N/A
3/31/202030,3337,2884,0766,519N/A
12/31/201929,1527,2504,4226,431N/A
9/30/201927,3486,505N/A4,503N/A
6/30/201924,9785,860N/A3,539N/A
3/31/201922,6245,521N/A3,404N/A
12/31/201821,2415,208N/A3,846N/A
9/30/201819,6185,186N/A4,303N/A
6/30/201819,9665,396N/A5,019N/A
3/31/201818,6314,345N/A4,937N/A
12/31/201717,9013,753N/A3,818N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: A290650 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (3.1%).

Earnings vs Market: A290650 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: A290650 is expected to become profitable in the next 3 years.

Revenue vs Market: A290650's revenue (61.3% per year) is forecast to grow faster than the KR market (12.8% per year).

High Growth Revenue: A290650's revenue (61.3% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: A290650's Return on Equity is forecast to be high in 3 years time (26.4%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/04/30 02:21
End of Day Share Price 2026/04/30 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

L&C BIO Co.,LTD is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Chae-eun LeeEugene Investment & Securities Co Ltd.
SungKyu HeoShinhan Investment Corp.
Seung-eun LeeYuanta Securities Korea Co., Ltd.